{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:36:06Z","timestamp":1793723766828,"version":"4.6.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T00:00:00Z","timestamp":1626048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T00:00:00Z","timestamp":1626048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1038\/s41401-021-00723-3","type":"journal-article","created":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T10:03:06Z","timestamp":1626084186000},"page":"933-940","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Hepatic Vps33b deficiency aggravates cholic acid-induced cholestatic liver injury in male mice"],"prefix":"10.1038","volume":"43","author":[{"given":"Kai-li","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-ming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-huan","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong-hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-chang","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,12]]},"reference":[{"key":"723_CR1","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","volume":"51","author":"European Association for the Study of the Liver.","year":"2009","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51:237\u201367.","journal-title":"J Hepatol"},{"key":"723_CR2","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/hep.28965","volume":"65","author":"PL Jansen","year":"2017","unstructured":"Jansen PL, Ghallab A, Vartak N, Reif R, Schaap FG, Hampe J, et al. The ascending pathophysiology of cholestatic liver disease. Hepatology. 2017;65:722\u201338.","journal-title":"Hepatology"},{"key":"723_CR3","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1002\/hep.28991","volume":"65","author":"M Trauner","year":"2017","unstructured":"Trauner M, Fuchs CD, Halilbasic E, Paumgartner G. New therapeutic concepts in bile acid transport and signaling for management of cholestasis. Hepatology. 2017;65:1393\u2013404.","journal-title":"Hepatology"},{"key":"723_CR4","doi-asserted-by":"publisher","first-page":"808","DOI":"10.2174\/1389200219666180427165035","volume":"19","author":"S Chatterjee","year":"2018","unstructured":"Chatterjee S, Annaert P. Drug-induced cholestasis: mechanisms, models, and markers. Curr Drug Metab. 2018;19:808\u201318.","journal-title":"Curr Drug Metab"},{"key":"723_CR5","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1007\/s00535-018-1484-9","volume":"53","author":"H Isayama","year":"2018","unstructured":"Isayama H, Tazuma S, Kokudo N, Tanaka A, Tsuyuguchi T, Nakazawa T, et al. Clinical guidelines for primary sclerosing cholangitis 2017. J Gastroenterol. 2018;53:1006\u201334.","journal-title":"J Gastroenterol"},{"key":"723_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","volume":"67","author":"European Association for the Study of the Liver.","year":"2017","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67:145\u201372.","journal-title":"J Hepatol"},{"key":"723_CR7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1159\/000015571","volume":"89","author":"L Carim","year":"2000","unstructured":"Carim L, Sumoy L, Andreu N, Estivill X, Escarceller M. Cloning, mapping and expression analysis of VPS33B, the human orthologue of rat Vps33b. Cytogenet Cell Genet. 2000;89:92\u20135.","journal-title":"Cytogenet Cell Genet"},{"key":"723_CR8","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.jhep.2017.01.001","volume":"66","author":"J Hanley","year":"2017","unstructured":"Hanley J, Dhar DK, Mazzacuva F, Fiadeiro R, Burden JJ, Lyne AM, et al. Vps33b is crucial for structural and functional hepatocyte polarity. J Hepatol. 2017;66:1001\u201311.","journal-title":"J Hepatol"},{"key":"723_CR9","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/ng1325","volume":"36","author":"P Gissen","year":"2004","unstructured":"Gissen P, Johnson CA, Morgan NV, Stapelbroek JM, Forshew T, Cooper WN, et al. Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome. Nat Genet. 2004;36:400\u20134.","journal-title":"Nat Genet"},{"key":"723_CR10","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/MPG.0b013e31817fcb3f","volume":"48","author":"JY Jang","year":"2009","unstructured":"Jang JY, Kim KM, Kim GH, Yu E, Lee JJ, Park YS, et al. Clinical characteristics and VPS33B mutations in patients with ARC syndrome. J Pediatr Gastroenterol Nutr. 2009;48:348\u201354.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"723_CR11","doi-asserted-by":"publisher","first-page":"175628481878740","DOI":"10.1177\/1756284818787400","volume":"11","author":"P Santiago","year":"2018","unstructured":"Santiago P, Scheinberg AR, Levy C. Cholestatic liver diseases: new targets, new therapies. Ther Adv Gastroenterol. 2018;11:1756284818787400.","journal-title":"Ther Adv Gastroenterol"},{"key":"723_CR12","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1002\/hep.30077","volume":"68","author":"C Wang","year":"2018","unstructured":"Wang C, Cheng Y, Zhang X, Li N, Zhang L, Wang S, et al. Vacuolar protein sorting 33B is a tumor suppressor in hepatocarcinogenesis. Hepatology. 2018;68:2239\u201353.","journal-title":"Hepatology"},{"key":"723_CR13","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3389\/fphar.2019.00276","volume":"10","author":"K Fu","year":"2019","unstructured":"Fu K, Wang C, Gao Y, Fan S, Zhang H, Sun J, et al. Metabolomics and lipidomics reveal the effect of hepatic Vps33b deficiency on bile acids and lipids metabolism. Front Pharmacol. 2019;10:276.","journal-title":"Front Pharmacol"},{"key":"723_CR14","doi-asserted-by":"publisher","first-page":"D1144","DOI":"10.1093\/nar\/gkr1013","volume":"40","author":"X Wang","year":"2012","unstructured":"Wang X, Spandidos A, Wang H, Seed B. PrimerBank: a PCR primer database for quantitative gene expression analysis, 2012 update. Nucleic Acids Res. 2012;40:D1144\u20139.","journal-title":"Nucleic Acids Res"},{"key":"723_CR15","doi-asserted-by":"publisher","first-page":"D792","DOI":"10.1093\/nar\/gkp1005","volume":"38","author":"A Spandidos","year":"2010","unstructured":"Spandidos A, Wang X, Wang H, Seed B. PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic Acids Res. 2010;38:D792\u20139.","journal-title":"Nucleic Acids Res"},{"key":"723_CR16","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s00439-006-0232-z","volume":"120","author":"P Gissen","year":"2006","unstructured":"Gissen P, Tee L, Johnson CA, Genin E, Caliebe A, Chitayat D, et al. Clinical and molecular genetic features of ARC syndrome. Hum Genet. 2006;120:396\u2013409.","journal-title":"Hum Genet"},{"key":"723_CR17","doi-asserted-by":"publisher","first-page":"4830","DOI":"10.3748\/wjg.v20.i16.4830","volume":"20","author":"JS Wang","year":"2014","unstructured":"Wang JS, Zhao J, Li LT. ARC syndrome with high GGT cholestasis caused by VPS33B mutations. World J Gastroenterol. 2014;20:4830\u20134.","journal-title":"World J Gastroenterol"},{"key":"723_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12016-019-08731-2","volume":"58","author":"W Chen","year":"2020","unstructured":"Chen W, Wei Y, Xiong A, Li Y, Guan H, Wang Q, et al. Comprehensive analysis of serum and fecal bile acid profiles and interaction with gut microbiota in primary biliary cholangitis. Clin Rev Allergy Immunol. 2020;58:25\u201338.","journal-title":"Clin Rev Allergy Immunol"},{"key":"723_CR19","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.1111\/bph.14035","volume":"174","author":"P Chen","year":"2017","unstructured":"Chen P, Li D, Chen Y, Sun J, Fu K, Guan L, et al. p53-mediated regulation of bile acid disposition attenuates cholic acid-induced cholestasis in mice. Br J Pharmacol. 2017;174:4345\u201361.","journal-title":"Br J Pharmacol"},{"key":"723_CR20","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1124\/dmd.113.056549","volume":"42","author":"P Chen","year":"2014","unstructured":"Chen P, Zeng H, Wang Y, Fan X, Xu C, Deng R, et al. Low dose of oleanolic acid protects against lithocholic acid-induced cholestasis in mice: potential involvement of nuclear factor-E2-related factor 2-mediated upregulation of multidrug resistance-associated proteins. Drug Metab Dispos. 2014;42:844\u201352.","journal-title":"Drug Metab Dispos"},{"key":"723_CR21","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3109\/00365528009182221","volume":"15","author":"A Bremmelgaard","year":"1980","unstructured":"Bremmelgaard A, Alme B. Analysis of plasma bile acid profiles in patients with liver diseases associated with cholestasis. Scand J Gastroenterol. 1980;15:593\u2013600.","journal-title":"Scand J Gastroenterol"},{"key":"723_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0009-8981(96)06305-X","volume":"251","author":"S Fischer","year":"1996","unstructured":"Fischer S, Beuers U, Spengler U, Zwiebel FM, Koebe HG. Hepatic levels of bile acids in end-stage chronic cholestatic liver disease. Clin Chim Acta. 1996;251:173\u201386.","journal-title":"Clin Chim Acta"},{"key":"723_CR23","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/sj.bjp.0707235","volume":"151","author":"S Teng","year":"2007","unstructured":"Teng S, Piquette-Miller M. Hepatoprotective role of PXR activation and MRP3 in cholic acid-induced cholestasis. Br J Pharmacol. 2007;151:367\u201376.","journal-title":"Br J Pharmacol"},{"key":"723_CR24","doi-asserted-by":"publisher","first-page":"12266","DOI":"10.1073\/pnas.1019678108","volume":"108","author":"DH Kim","year":"2011","unstructured":"Kim DH, Lee JW. Tumor suppressor p53 regulates bile acid homeostasis via small heterodimer partner. Proc Natl Acad Sci USA. 2011;108:12266\u201370.","journal-title":"Proc Natl Acad Sci USA"},{"key":"723_CR25","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/cphy.c120023","volume":"3","author":"JY Chiang","year":"2013","unstructured":"Chiang JY. Bile acid metabolism and signaling. Compr Physiol. 2013;3:1191\u2013212.","journal-title":"Compr Physiol"},{"key":"723_CR26","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/hep.27964","volume":"62","author":"JY Chiang","year":"2015","unstructured":"Chiang JY. Negative feedback regulation of bile acid metabolism: impact on liver metabolism and diseases. Hepatology. 2015;62:1315\u20137.","journal-title":"Hepatology"},{"key":"723_CR27","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.cmet.2015.01.007","volume":"21","author":"TQ de Aguiar Vallim","year":"2015","unstructured":"de Aguiar Vallim TQ, Tarling EJ, Ahn H, Hagey LR, Romanoski CE, Lee RG, et al. MAFG is a transcriptional repressor of bile acid synthesis and metabolism. Cell Metab. 2015;21:298\u2013311.","journal-title":"Cell Metab"},{"key":"723_CR28","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1172\/JCI0216309","volume":"110","author":"J Li-Hawkins","year":"2002","unstructured":"Li-Hawkins J, Gafvels M, Olin M, Lund EG, Andersson U, Schuster G, et al. Cholic acid mediates negative feedback regulation of bile acid synthesis in mice. J Clin Invest. 2002;110:1191\u2013200.","journal-title":"J Clin Invest"},{"key":"723_CR29","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1124\/dmd.113.055772","volume":"42","author":"D Keppler","year":"2014","unstructured":"Keppler D. The roles of MRP2, MRP3, OATP1B1, and OATP1B3 in conjugated hyperbilirubinemia. Drug Metab Dispos. 2014;42:561\u20135.","journal-title":"Drug Metab Dispos"},{"key":"723_CR30","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1053\/jhep.2001.22646","volume":"33","author":"G Zollner","year":"2001","unstructured":"Zollner G, Fickert P, Zenz R, Fuchsbichler A, Stumptner C, Kenner L, et al. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology. 2001;33:633\u201346.","journal-title":"Hepatology"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00723-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00723-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00723-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T13:38:54Z","timestamp":1648820334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00723-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,12]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["723"],"URL":"https:\/\/doi.org\/10.1038\/s41401-021-00723-3","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,12]]},"assertion":[{"value":"25 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}